Development and Prospective Randomized Evaluation of a Decision Aid for Prostate-specific Antigen-based Early Detection of Prostate Cancer in Men Aged Between 55 and 69Yr: The PSAInForm Trial.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 30665815.
- Also identified by DOI 10.1016/j.eururo.2019.01.008.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
For men interested in early detection of prostate cancer, the potential impact on decisional conflict of a decision aid with or without cost compensation for the prostate-specific antigen test will be investigated.
Medical subject headings
- Decision Support Techniques
- Early Detection of Cancer
- Prostate-Specific Antigen
- Prostatic Neoplasms